← Eichor
Condition: Oral Cavity Cancer Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Oral Cavity Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Proactive Risk-based Optimization & Notifications for Treatment & Outcomes in Head & Neck Cancer
NA · 1 location(s) · Centre hospitalier de l'Université de Montréal (CHUM) · NCT07180901Spectroscopic Analysis of Tongue Tumor Samples.
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire, Amiens · NCT05104619DOVIPA, a Study Evaluating Efficacy and Safety of DOstarlimab and VItamin D3 With mFOLFIRINOX in PAncreatic Cancer
Phase 2 · 5 location(s) · Hopital Foch · NCT06757244Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Phase 1/Phase 2 · 27 location(s) · Institut de Recherches Internationales Servier · NCT05786924AI-based Physiotherapy for Oral Cancer Patients
NA · 2 location(s) · National Taiwan University Hospital · NCT06785051Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patient
Phase 2 · 153 location(s) · NRG Oncology · NCT06532279Study to Identify Biomarkers of Oral Cavity Cancer Response to Neoadjuvant Immunotherapy Prior to Definitive Surgery
NA · 1 location(s) · University of Wisconsin, Madison · NCT07343596Sentinel Node Biopsy Versus Limited Elective Neck Dissection in Early Cancers of Oral Cavity NoDe Negative
NA · 3 location(s) · Tata Memorial Hospital · NCT05774483Validation of the O-bridge Protocol: a Prospective, Multicenter Trial
Phase N/A · 5 location(s) · AZ Sint-Jan AV · NCT04007783Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Hepatic Im
Phase 1 · 22 location(s) · Taiho Oncology, Inc. · NCT04953910A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Ca
Phase 3 · 205 location(s) · Merus B.V. · NCT06525220Evaluation of the Benefit of a New Surgical Procedure According to IDEAL Recommendations for ORL Cancer Patients: the Ex
NA · 4 location(s) · Institut Claudius Regaud · NCT05757817Estimating Jaw, Neck, and Shoulder Range of Motion Using an AI Model
Phase N/A · 1 location(s) · National Taiwan University Hospital · NCT06629038A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensi
Phase N/A · 13 location(s) · AbbVie · NCT05317494Rice Bran Supplementation for Radiation-Induced Oral Mucositis in Head and Neck Cancer
NA · 1 location(s) · Christina Milad Lobos · NCT07242859Study of ART6043 in Advanced/Metastatic Solid Tumors Patients (POLKA)
Phase 1/Phase 2 · 12 location(s) · Artios Pharma Ltd · NCT05898399The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
Phase 3 · 73 location(s) · American Society of Clinical Oncology · NCT06377852Impact of Changing the Appearance of Oral Antineoplastics on Adherence and Continuity of Treatment, Patient-reported Hea
Phase N/A · 1 location(s) · Universidad Miguel Hernandez de Elche · NCT07664683Detection of Oral and Throat Cancers Using OralViome Cancer Testing System
Phase N/A · 1 location(s) · Viome · NCT05451303Adenoid Cystic Carcinoma and Carbon Ion Only Irradiation
Phase 2 · 1 location(s) · Heidelberg University · NCT04214366BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or S
Phase 2 · 225 location(s) · National Cancer Institute (NCI) · NCT05136196Antibiotic Treatment Effects on Intratumoral Bacteria Modulation in Surgical Patients With Oral Cancer
Phase 2 · 1 location(s) · Case Comprehensive Cancer Center · NCT06627270A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activat
Phase 1 · 15 location(s) · Jazz Pharmaceuticals · NCT05557045Newer Therapeutic Targets in Head and Neck Cancers
Phase N/A · 1 location(s) · Banaras Hindu University · NCT05382585Radial Forearm Donor Site Closure
NA · 1 location(s) · University of British Columbia · NCT05740033Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-esca
Phase 2 · 1 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT07209189Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas
Phase 2 · 13 location(s) · Dana-Farber Cancer Institute · NCT04620187A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers
Phase 2 · 2 location(s) · Glenn J. Hanna · NCT06805617Telmisartan in Prostate Cancer
Phase 1 · 1 location(s) · Tyler J Curiel · NCT06168487Cemiplimab and Cetuximab Prior Salvage Surgery in Patients With Recurrent Oral Cavity and HPV-negative Oropharyngeal Squ
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT06448026
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.